These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7966066)

  • 1. Osteocalcin in patients with rheumatoid arthritis. A one-year followup study.
    Franck H; Ittel TH; Tasch O; Herborn G; Rau R
    J Rheumatol; 1994 Jul; 21(7):1256-9. PubMed ID: 7966066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R; Schleusser B; Herborn G; Karger T
    J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum matrix metalloproteinase 3 levels during treatment with sulfasalazine or combination of methotrexate and sulfasalazine in patients with early rheumatoid arthritis.
    Posthumus MD; Limburg PC; Westra J; van Leeuwen MA; van Rijswijk MH
    J Rheumatol; 2002 May; 29(5):883-9. PubMed ID: 12022344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum osteocalcin levels in rheumatoid arthritis: a marker for accelerated bone turnover in late onset rheumatoid arthritis.
    Marhoffer W; Schatz H; Stracke H; Ullmann J; Schmidt K; Federlin K
    J Rheumatol; 1991 Aug; 18(8):1158-62. PubMed ID: 1941815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of low dose methotrexate on markers of bone metabolism in patients with rheumatoid arthritis.
    El Miedany YM; Abubakr IH; El Baddini M
    J Rheumatol; 1998 Nov; 25(11):2083-7. PubMed ID: 9818648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients.
    Ranganath VK; Elashoff DA; Khanna D; Park G; Peter JB; Paulus HE;
    J Rheumatol; 2005 Jun; 32(6):1040-2. PubMed ID: 15940764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study.
    Lehman AJ; Esdaile JM; Klinkhoff AV; Grant E; Fitzgerald A; Canvin J;
    Arthritis Rheum; 2005 May; 52(5):1360-70. PubMed ID: 15880810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
    Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
    Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gold sodium thiomalate compared to low dose methotrexate in the treatment of rheumatoid arthritis--a randomized, double blind 26-week trial.
    Morassut P; Goldstein R; Cyr M; Karsh J; McKendry RJ
    J Rheumatol; 1989 Mar; 16(3):302-6. PubMed ID: 2498513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of additive DMARD therapy in patients with rheumatoid arthritis. Double blind controlled trial using bucillamine and placebo with maintenance doses of gold sodium thiomalate.
    Yasuda M; Sakai K; Oribe M; Yoshioka K; Takahashi H; Ohtsuka E; Wada T; Shiokawa S; Yamamoto M; Ichibangase Y
    J Rheumatol; 1994 Jan; 21(1):44-50. PubMed ID: 8151586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
    Maradit-Kremers H; Nicola PJ; Crowson CS; O'Fallon WM; Gabriel SE
    J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of elevated serum interleukin-6 levels in rheumatoid arthritis: correlation with erythrocyte sedimentation rate or C-reactive protein.
    Cohick CB; Furst DE; Quagliata S; Corcoran KA; Steere KJ; Yager JG; Lindsley HB
    J Lab Clin Med; 1994 May; 123(5):721-7. PubMed ID: 8195678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry.
    Weaver AL; Lautzenheiser RL; Schiff MH; Gibofsky A; Perruquet JL; Luetkemeyer J; Paulus HE; Xia HA; Leff JA;
    Curr Med Res Opin; 2006 Jan; 22(1):185-98. PubMed ID: 16393444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can collagen type II sustain a methotrexate-induced therapeutic effect in patients with long-standing rheumatoid arthritis? A double-blind, randomized trial.
    Häuselmann HJ; Caravatti M; Seifert B; Wang K; Bruckner P; Stucki G; Michel BA
    Br J Rheumatol; 1998 Oct; 37(10):1110-7. PubMed ID: 9825751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone alkaline phosphatase in rheumatoid arthritis: a longitudinal study.
    Beyeler C; Banks R; Thompson D; Forbes MA; Cooper EH; Bird HA
    J Rheumatol; 1996 Feb; 23(2):241-4. PubMed ID: 8882026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 10 year prospective followup of patients with rheumatoid arthritis 1986-96.
    Gordon P; West J; Jones H; Gibson T
    J Rheumatol; 2001 Nov; 28(11):2409-15. PubMed ID: 11708411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) in patients with early rheumatoid arthritis.
    Klimiuk PA; Fiedorczyk M; Sierakowski S; Chwiecko J
    Scand J Rheumatol; 2007; 36(5):345-50. PubMed ID: 17963163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects.
    Hurst S; Kallan MJ; Wolfe FJ; Fries JF; Albert DA
    J Rheumatol; 2002 Aug; 29(8):1639-45. PubMed ID: 12180722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.